EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication



RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication



Frontiers in Endocrinology 4: 105-105



Obesity is associated with inflammation and type 2 diabetes. Innate immune system comprised of cellular and molecular components plays an important role in the inflammatory reactions. Immune cells like macrophages and their cell surface pattern-recognition receptors (PRRs) are representative for innate immunity promoting inflammatory reactions. The receptor for advanced glycation end-products (RAGE) is a member of PRRs and a proinflammatory molecular device that mediates danger signals to the body. The expression of RAGE is observed in adipocytes as well as immune cells, endothelial cells, and pancreatic β cells under certain conditions. It has been reported that RAGE is implicated in adipocyte hypertrophy and insulin resistance. RAGE-mediated regulation of adiposity and inflammation may attribute to type 2 diabetes and diabetic vascular complications.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333021

Download citation: RISBibTeXText

PMID: 23970880

DOI: 10.3389/fendo.2013.00105



Related references

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 185(1): 70-77, 2005

Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling. American Journal of Physiology. Heart and Circulatory Physiology 295(2): H475-H476, 2008

Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 120(5): 277-281, 2013

Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication. Current Pharmaceutical Design 14(5): 487-495, 2008

EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes. Molecular Nutrition & Food Research 57(12): 2264-2268, 2014

Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. Gene 500(1): 1-9, 2012

TLR4 and RAGE: similar routes leading to inflammation in type 2 diabetic patients. Diabetes & Metabolism 37(4): 336-342, 2012

The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification. Journal of Diabetes Research 2016: 6809703-6809703, 2016

The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation. Journal of Molecular Medicine 91(12): 1329-1331, 2014

Soluble forms of RAGE: an index of vascular stress? A commentary on "Soluble RAGE in type 2 diabetes: association with oxidative stress". Free Radical Biology & Medicine 43(4): 506-510, 2007

Decreased activities of daily living and physical activity related to diabetic vascular complication in the elderly patients with Type 2 diabetes Two-year follow-up study. Diabetologia 46(Supplement 2): A19, August, 2003

Research update on the AGE/RAGE signaling mediated vascular calcification in diabetes. Zhonghua Xin Xue Guan Bing Za Zhi 46(9): 745-750, 2018

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Current Atherosclerosis Reports 4(3): 228-237, 2002

Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?. Experimental and Molecular Pathology 102(3): 505-514, 2017

Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chemico-Biological Interactions 250: 59-67, 2016